Welcome to our dedicated page for Lifestance Health Group news (Ticker: LFST), a resource for investors and traders seeking the latest updates and insights on Lifestance Health Group stock.
LifeStance Health Group, Inc. (Nasdaq: LFST) is a mental healthcare company that focuses on outpatient services and regularly issues news and updates about its operations. The company describes itself as one of the nation’s largest providers of virtual and in-person outpatient mental healthcare for children, adolescents and adults, and its news flow reflects both its clinical focus and its role as a public company.
On this page, readers can find news items such as quarterly earnings results, financial outlooks and operational metrics. LifeStance’s earnings releases discuss topics like revenue, visit volumes, clinician base, Center Margin, Adjusted EBITDA and Free Cash Flow, along with commentary from management on business performance and guidance. These updates provide insight into how the company’s outpatient mental health services translate into financial and operating results.
LifeStance also publishes announcements about participation in healthcare investor conferences hosted by organizations such as UBS, Morgan Stanley and Goldman Sachs. These releases typically include details about presentation dates, times and webcast availability, and they underscore the company’s ongoing engagement with the investment community.
In addition, LifeStance issues news related to corporate governance, including changes to its board of directors, and survey-based research on mental health topics. For example, the company has shared survey findings on how the holiday season affects mental health, addressing themes like seasonal stress, social pressure, loneliness and family dynamics. Together, these news items offer a view into LifeStance’s financial performance, strategic priorities and perspective on mental health trends.
Investors, analysts and others interested in LFST can use this news feed to follow the company’s regular earnings communications, conference appearances, governance updates and mental health surveys in one place.
LifeStance Health Group, Inc. (NASDAQ: LFST) will release its second quarter earnings after market close on August 9, 2022. A live earnings conference call is scheduled for the same day at 4:30 p.m. Eastern Time, accessible via phone or a real-time audio webcast on the Investor Relations website. LifeStance, founded in 2017, is a leading provider of outpatient mental health care, employing around 5,000 professionals across 500 centers in 32 states. The company aims to enhance access to affordable mental health services for individuals of all ages.
LifeStance Health Foundation has appointed Gwen Booth as its first Executive Director, effective July 1, 2022. Booth will focus on enhancing access to mental health services for vulnerable populations, including youth and underrepresented communities. The Foundation has granted over $400,000 to various organizations aiming to destigmatize mental health care. Booth's background includes leadership roles in healthcare, and she aims to address barriers to affordable mental healthcare, advancing the Foundation's mission to unify mental and physical healthcare.
LifeStance Health Group, Inc. (NASDAQ: LFST), a leading outpatient mental health care provider, will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022, at 11:20 a.m. PT. CEO Michael Lester, COO Danish Qureshi, and CFO J. Michael Bruff will present at the event moderated by Jamie Perse. Attendees can access the live webcast on LifeStance's Investor Relations website, where a replay will also be available. Danish Qureshi's appointment as COO takes effect on July 1, 2022.
LifeStance Health (NASDAQ: LFST) announces the retirement of COO Gwen Booth, who will become Executive Director of the LifeStance Health Foundation, which aims to improve mental health access. Danish Qureshi, previously Chief Growth Officer, has been appointed as the new COO effective July 1, 2022. Booth has been with the company since its founding in 2017. Qureshi has a strong track record in growing the company and enhancing mental health services. The Foundation, established in 2021, has already awarded over $400,000 to support mental health initiatives.
LifeStance Health (NASDAQ: LFST), a leading provider in outpatient mental health care, will present at the UBS Global Healthcare Conference on May 25, 2022. Presenters include CEO Michael Lester, CFO J. Michael Bruff, and Chief Growth Officer Danish Qureshi. The presentation is scheduled for 7:45 a.m. Eastern time and will be moderated by Kevin Caliendo. A live webcast will be available on the LifeStance Health Investor Relations website, with a replay following the event. LifeStance employs approximately 5,000 professionals across 32 states.
LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q1 2022 revenue of $203.1 million, a 42% increase from the prior year. Total clinicians grew 51% to 4,989, with a net addition of 199 clinicians. However, net loss surged to $62.3 million, primarily due to stock-based compensation costs of $59.9 million. Adjusted EBITDA remained stable at $12.5 million. The company reaffirmed full-year 2022 revenue guidance of $865 million to $885 million.
LifeStance Health Group, Inc. (NASDAQ: LFST) is set to release its first quarter earnings on May 9, 2022, after market close. Following the earnings announcement, the company will conduct a conference call at 4:30 p.m. ET to discuss its financial performance. Interested participants can join via a toll-free number or listen to a live webcast through LifeStance's Investor Relations website. Founded in 2017, LifeStance is a major provider of outpatient mental health care, employing roughly 4,800 professionals across 32 states.
Summary not available.
LifeStance Health Group (LFST) reported a 61% revenue growth in Q4 2021, reaching $190.1 million, and a full-year revenue of $667.5 million, up 77% from 2020. However, the company posted a net loss of $108 million for Q4 and $307.2 million for the full year, primarily due to stock-based compensation. LifeStance anticipates a revenue growth rate in the low 30s for 2022, with expected revenue between $865 and $885 million. The company expanded its clinician base by 55% to 4,790 clinicians, demonstrating its ongoing growth strategy.
LifeStance Health Group (NASDAQ: LFST), a leading provider of outpatient mental health care, will announce its fourth quarter earnings on March 10, 2022, after market close. A conference call to discuss the results is scheduled for the same day at 4:30 PM ET. Investors can join by calling 1-888-660-0230 or via webcast at the LifeStance Investor Relations site. Established in 2017, LifeStance operates around 500 centers and employs about 4,375 mental health professionals across 31 states, striving to enhance access to affordable mental health care.